-
CR Boya Bio-Pharmaceutical’s Strategic Foray: Acquiring Green Cross HK for $250M to Expand Biopharma Dominance
•
In a significant development for the biopharmaceutical industry, China Resources Medical Holdings Company Limited and its subsidiary, CR Boya Biological Pharmacy Co. Ltd. (SHE: 300294), have entered into a strategic partnership and equity transfer agreement with GC Corp. The agreement facilitates CR Boya’s acquisition of a 100% stake in Green…
